Discovery Lens
C Combination Innovation
Two separate worlds finally connect — and the intersection is a product
One-Liner
a smart toilet seat attachment ($149) with optical sensors and AI that performs daily urinalysis and stool analysis, tracking health trends over months and flagging early warning signs.
Kill Reason
Consumer-grade optical urinalysis accurate enough to make health claims does not exist at a $149 price point today — TOTO's equivalent technology costs $4,000 or more — and any health diagnostic claims would require FDA Class II medical device clearance, a multi-year regulatory pathway that would consume far more capital than the product's revenue potential at this price.
What do you think?
Related ideas you can explore free:
killed: Urine and stool analysis for glucose monitoring, cancer screening, and kidney function markers falls squarely into FDA Class II/III medical device territory, requiring clinical trials and 510(k) or PMA approval costing millions and taking years. The entire high-value use case — the reason anyone would buy this — is legally undeliverable without regulatory clearance the product cannot realistically obtain.
killed: Amazon Alexa Together and comparable remote family monitoring services already serve this exact use case at consumer price points with embedded distribution advantages that a standalone WiFi sensing module cannot overcome. Daily routine monitoring and anomaly alerting for elderly relatives is a feature, not a product, in the current competitive landscape.
killed: Personal injury narrative reports require specific medico-legal structure, but the format is well-documented in public templates and any chiropractor with a configured AI prompt can replicate the output — there is no proprietary data asset, workflow lock-in, or network effect to justify a subscription fee against a commodity capability.